FCF Grants Awarded to University Hospital Tübingen

Total grants: 2

• Uncovering the immunopeptidome of fibrolamellar cancer to expand the target repertoire for T cell-based immunotherapy development — Principal investigator(s): Jens Bauer — 2025
• FusionVAC22_02: DNAJB1-PRKACA fusion transcript-based peptide vaccine for fibrolamellar hepatocellular carcinoma patients — Principal investigator(s): Juliane S. Walz — 2024

This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to University Hospital Tübingen.